Paul Peter Tak, CEO of Candel Therapeutics, Discusses the Treatment of Glioblastoma

[@jbp4182]

This is one of the most exciting companies developing cancer treatments. One important thing left out of this video was the finding that in patients with multiple tumors, the positive effects of CAN3110 were seen in tumors NOT injected with no effects in healthy brain tissue. This supports the idea that this treatment may act as a vaccine by teaching the patients immune system to attack those specific cancer cells. This is what the cure will look like.